Search
for
Sort by
Research 781–810 of 1000+
- Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Clinical efficacy and safety of low‐dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism
- Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- THE EFFECT OF SPIRONOLACTONE ON HIRSUTISM AND FEMALE ANDROGEN METABOLISM
- A systematic review of antiandrogens and feminization in transgender women
- Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study
- Differential effects of melatonin as a broad range UV-damage preventive dermato-endocrine regulator
- Androgens Induce Nongenomic Stimulation of Colonic Contractile Activity through Induction of Calcium Sensitization and Phosphorylation of LC20 and CPI-17
- Effects of two estroprogestins containing ethynilestradiol 30mug and drospirenone 3 mg and ethynilestradiol 30mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations
- Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome
- Psychological aspects of hyperandrogenic states in late adolescent and young women
- Diagnostic approach to low‐renin hypertension
- Clinical characteristics of polycystic ovary syndrome: investigating differences in White and South Asian women
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- THE FIBROBLAST AS A MODEL FOR ANDROGEN RESISTANT STATES
- CHRONIC TREATMENT REGIMENS FOR HIRSUTISM IN WOMEN: EFFECT ON BLOOD PRODUCTION RATES OF TESTOSTERONE AND ON HAIR GROWTH
- Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women
- Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight
- Congenital adrenal hyperplasia
- Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review
- LACK OF EFFECT OF OESTROGENS ON ADRENAL ANDROGEN SECRETION IN CHILDREN AND ADOLESCENTS WITH A COMMENT ON OESTROGENS AND PUBIC HAIR GROWTH
- The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis
- Identification and characterization of an antisense RNA transcript (gfg) from the human basic fibroblast growth factor gene.
- A population‐based nested case–control study: the use of 5‐alpha‐reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia
- Relapse of hirsutism following long‐term successful treatment with oestrogen–progestogen combination
- Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries
- High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS)
- 5α‐Reductase inhibitors and prostatic disease